Delivery Order SPE2DB22D9209-SPE2DB23FL5SJ

Award Date 3/17/23
Potential Completion Date 4/7/23
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $4,568 delivery order to DMS Pharmaceutical Group Inc. for 4562162775 units of BOTOX 100 unit vials. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to various Department of Defense customers. DMS Pharmaceutical will deliver the BOTOX vials to locations in Park Ridge, Illinois between September 12 and October 3, 2023. No set aside designation or subcontracting...
<p>The Defense Logistics Agency awarded a $3,234.25 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 200 unit vials of BOTOX. The place of performance is Park Ridge, Illinois. The order was placed under an existing contract vehicle to supply pharmaceutical products and services to DOD. DMS Pharmaceutical will deliver the BOTOX vials by May 25, 2023 to support DLA's medical supply needs. No set aside designation or subcontractors were identified.</p>
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $64,685 delivery order to DMS Pharmaceutical Group Inc. for 200 unit vials of BOTOX. The firm fixed price order is being fulfilled under the Prime Vendor Program, which supports DLA's mission to provide medical supplies and pharmaceuticals to military treatment facilities worldwide. Park Ridge, Illinois-based DMS Pharmaceutical will deliver the BOTOX vials between September 14 and...
The Defense Logistics Agency awarded a $64,685 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 200 unit vials of BOTOX. The place of performance is Park Ridge, Illinois. The order is being funded under DLA's pharmaceutical and medical commodities program and is valued at approximately $65 thousand. DMS will deliver the BOTOX vials to the customer between July 20 and August 10, 2023. No subcontractors or set aside designations were identified in the award information.
This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for $15,524.40 worth of 200 unit vials of BOTOX to be delivered by March 13, 2023. The firm fixed price contract was awarded on February 17, 2023 without a set-aside designation. DMS Pharmaceutical Group Inc. will fulfill the order from its place of performance in Park Ridge, Illinois. The Defense Logistics Agency supports military readiness by procuring and providing logistics support for medical...
The Defense Logistics Agency awarded a $25,874 delivery order to DMS Pharmaceutical Group Inc. to supply 200 unit vials of BOTOX. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide the pharmaceutical products to agencies of the Department of Defense. Performance will take place in Park Ridge, Illinois over a three week period concluding at the end of June. No set aside designation or subcontracting details were provided in the award...
The Defense Logistics Agency awarded a $913 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4560347651 units of 100 unit vials of BOTOX with an anticipated completion date of April 11, 2023. No set-aside provisions were applied to this award placed under an unspecified agency-wide contract vehicle. The order supports standard pharmaceutical needs within the Defense Logistics Agency's medical supply chain. DMS Pharmaceutical Group Inc....
<p>This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for $15,524.40 worth of 200 unit vials of BOTOX, to be delivered by May 30, 2023. The firm fixed price contract was awarded on May 8, 2023 without a set-aside designation. DMS Pharmaceutical Group Inc. will fulfill the order for the Defense Logistics Agency from its place of performance in Park Ridge, Illinois.</p>
The Defense Logistics Agency awarded a $6,852 delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois under an indefinite-delivery/indefinite-quantity contract vehicle. The firm fixed price order is for 4560159023 100 unit vials of BOTOX to be delivered by March 22, 2023. No set-aside provisions were applied to this award to supply the pharmaceutical products in support of DLA missions. DMS Pharmaceutical Group Inc. will perform as the prime contractor, delivering the BOTOX vials...
The Defense Logistics Agency awarded a $3,881.10 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4560293133 units of BOTOX 200 unit vials with an estimated completion date of April 3, 2023. No set-aside designation was used for this award placed under an unspecified government-wide acquisition contract vehicle. The delivery order will supply the Defense Logistics Agency with botulinum toxin injection vials to support its medical supply...
  • SPE2DB22D9209
    Indefinite Delivery Contract
  • SPE2DB22D9209-SPE2DB23FL5SJ
    Delivery Order

The Defense Logistics Agency awarded a $15,524 delivery order to DMS Pharmaceutical Group Inc. for 200 unit vials of BOTOX. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to various Department of Defense components. DMS Pharmaceutical will deliver the vials to a customer located in Park Ridge, Illinois, with performance required between March 17 and April 7, 2023. No set aside designation or subcontracting details were provided in the award information.

Generated 12/31/23, 6:15 AM